Academic performance
AI-powered
biopharmaceutical company
Brisbane Times
care access
clinical trials
global cooperation
imports
indigenous communities
job displacement
NASA
neuro-ophthalmology
New York
Oculis
ozone
Privosegtor
Queensland
Regulation
satellites
Smacking
Summit 2026
TEMPO
trauma
UCL
Washington D.C.
week's news
unexplained phenomenon
trust
transformative power
TakeMe2Space
star tracker
sharing circles
research
quiz
qualitative data collection
Physical punishment
ophthalmology
nitrogen dioxide
new format
navigation
May 2026
IN-SPACE funding
India
heart health
cybersecurity threats
children
bullying
bioweapons
Air Pollution
AI
Articles tagged neuro-ophthalmology in Science
Oculis to Present New Neuro-Ophthalmic Drug at Summit 2026
Oculis Holding AG, a global biopharmaceutical company based in Zug, Switzerland, will present its breakthrough neuro-ophthalmology drug Privosegtor during upcoming clinical trials at the Summit 2026. This announcement highlights Oculis' ongoing efforts to address significant unmet medical needs in ophthalmology and neuro-ophthalmology.